Patheon, a provider of drug development and manufacturing services, has established a new subsidiary Patheon KK, based in Tokyo, Japan.
Subscribe to our email newsletter
Patheon KK will operate from a newly established business office located in the Nihonbashi district of central Tokyo and will support Patheon’s business requirements in the region.
Patheon has said that local staff will be added to the Tokyo office to fulfill the company’s growing Asian business development and service support requirements.
Wes Wheeler, president and CEO of Patheon, said: “This provides Patheon with a permanent presence in Japan to target new customers and support existing ones in Japan and other Asian markets. It demonstrates our commitment to build on our existing customer base in this very important region.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.